Campbell & Co Investment Adviser’s Evolent Health EVH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,825	Closed	-$178K	–	1184
2025 Q2	$178K	Sell	15,825 -20,865	-57%	-$192K	0.01%	1068
2025 Q1	$347K	Buy	36,690 +24,284	+196%	+$245K	0.03%	808
2024 Q4	$140K	Buy	+12,406	New	+$218K	0.01%	1002
2024 Q3	–	Sell	-12,057	Closed	-$231K	–	1160
2024 Q2	$231K	Buy	12,057 +1,722	+17%	+$44K	0.02%	922
2024 Q1	$339K	Buy	+10,335	New	+$330K	0.03%	858
2023 Q2	–	Sell	-22,759	Closed	-$739K	–	959
2023 Q1	$739K	Buy	+22,759	New	+$720K	0.14%	272
2022 Q4	–	Sell	-20,263	Closed	-$728K	–	829
2022 Q3	$728K	Buy	+20,263	New	+$714K	0.17%	196
2018 Q4	–	Sell	-9,900	Closed	-$281K	–	381
2018 Q3	$281K	Sell	9,900 -8,400	-46%	-$200K	0.19%	247
2018 Q2	$385K	Buy	+18,300	New	+$346K	0.3%	116

Other funds holding EVH

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Campbell & Co Investment Adviser's EVH Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 15,825 shares — an estimated $178K sold.

Campbell & Co Investment Adviser first reported a position in EVH in Q2 2018 and held it in 9 quarters. The position peaked at $739K in Q1 2023. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

Campbell & Co Investment Adviser reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 15,825 Evolent Health shares in Q3 2025, an estimated $178K.
Campbell & Co Investment Adviser first reported a position in Evolent Health in Q2 2018 and held it in 9 quarters.
Campbell & Co Investment Adviser's Evolent Health position peaked at $739K in Q1 2023.
240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.